Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
NCT: NCT06687603 · RECRUITING
Brief Summary
The goal of this clinical trial is to develop a method to detect Barrett's esophagus in individuals with a new office based diagnostic test. Barrett's esophagus is a condition in which the flat pink lining of the swallowing tube that connects the mouth to the stomach (the esophagus) becomes damaged by acid reflux. The main question it aims to answer is: Can this approach demonstrate efficacy for screening of Barrett's esophagus? Participants will: * Participate in a questionnaire. * Undergo a capsule balloon test, called EsoCheck. * Have their EsoCheck sample sent to the laboratory for an EsoGuard test, which is used to detect Barrett's esophagus. * Participants will undergo upper endoscopy as part of standard of care.
Frequently Asked Questions
What is Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms?
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms is a clinical trial registered under NCT06687603. Current status: RECRUITING.
What is the status of NCT06687603?
The current status of NCT06687603 (Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms) is: RECRUITING.
When did Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms start?
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms started on 2025-03-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.